Anrukinzumab
Encyclopedia
Anrukinzumab is a humanized monoclonal antibody designed for the treatment of asthma
.
Anrukinzumab was developed by Wyeth
.
Asthma
Asthma is the common chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. Symptoms include wheezing, coughing, chest tightness, and shortness of breath...
.
Anrukinzumab was developed by Wyeth
Wyeth
Wyeth, formerly one of the companies owned by American Home Products Corporation , was a pharmaceutical company. The company was based in Madison, New Jersey, USA...
.